Lv12
60 积分 2025-11-11 加入
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
6小时前
已完结
ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
7小时前
已完结
ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy
7小时前
已完结
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
13天前
已完结
Abscopal effect: A promising paradigm for managing metastatic cancer
13天前
已完结
Radiation as an immune modulator: mechanisms and implications for combination with immunotherapy
1个月前
已完结
Emerging evidence for adapting radiotherapy to immunotherapy
1个月前
已完结
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
1个月前
已完结
Therapy with oncolytic viruses: progress and challenges
1个月前
已完结
Navigating CAR-T cells through the solid-tumour microenvironment
1个月前
已完结
皖公网安备34019202002308
